Dr Holst is the founder of Hervolution. He has significant immunology experience, making pivotal discoveries in the field. He has taken virus-vectored vaccines further by developing the first clinically effective genetic adjuvants. Dr Holst’s prior inventions are in clinical trials and licensed to GSK.